Want to see AU:RHY full AI Analyst Report?
Rhythm Biosciences Ltd. (RHY) Ratios
Rhythm Biosciences Ltd. Ratios
AU:RHY's free cash flow for Q4 2026 was $-3.04M. For the 2026 fiscal year, AU:RHY's free cash flow was decreased by $-24.78K and operating cash flow was $-3.01M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.61 | 0.84 | 1.58 | 4.03 | 8.33 |
| Quick Ratio | 3.59 | 0.80 | 1.58 | 2.47 | 8.33 |
| Cash Ratio | 3.22 | 0.65 | 1.26 | 2.34 | 8.10 |
| Solvency Ratio | -5.04 | -1.67 | -10.22 | -4.41 | -8.16 |
| Operating Cash Flow Ratio | -5.02 | -1.35 | -10.92 | -3.94 | -6.67 |
| Short-Term Operating Cash Flow Coverage | -30.40 | -2.92 | -78.33 | -82.24 | -72.66 |
| Net Current Asset Value | $ 2.62M | $ -360.29K | $ 235.13K | $ 5.30M | $ 6.71M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.39 | 0.11 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.07 | 1.68 | 0.19 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.06 | 0.63 | 0.16 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 4.29 | 1.75 | 1.31 | 1.14 |
| Debt Service Coverage Ratio | -23.05 | -3.31 | -81.66 | -131.30 | -78.66 |
| Interest Coverage Ratio | -99.70 | -52.95 | -2133.95 | 0.00 | -349.17 |
| Debt to Market Cap | 0.01 | 0.07 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.43 | 0.08 | 0.07 | 0.36 | 0.66 |
| Profitability Margins | |||||
| Gross Profit Margin | -5151.30% | 92.95% | -80.30% | 93.86% | -4.18% |
| EBIT Margin | -8739.15% | -116.85% | -505.55% | -364.92% | -461.72% |
| EBITDA Margin | -8517.35% | -110.68% | -493.79% | -358.82% | -457.52% |
| Operating Profit Margin | -8739.15% | -110.68% | -396.86% | -372.80% | -359.17% |
| Pretax Profit Margin | -8795.48% | -119.97% | -505.74% | -265.44% | -362.34% |
| Net Profit Margin | -6948.85% | -119.97% | -405.74% | -265.44% | -362.34% |
| Continuous Operations Profit Margin | -6948.85% | -119.97% | -405.74% | -265.44% | -362.34% |
| Net Income Per EBT | 79.00% | 100.00% | 80.23% | 100.00% | 100.00% |
| EBT Per EBIT | 100.64% | 108.39% | 127.43% | 71.20% | 100.88% |
| Return on Assets (ROA) | -124.14% | -135.23% | -451.50% | -106.79% | -104.22% |
| Return on Equity (ROE) | -163.04% | -580.30% | -790.74% | -139.89% | -119.29% |
| Return on Capital Employed (ROCE) | -199.70% | -525.12% | -700.93% | -194.64% | -116.14% |
| Return on Invested Capital (ROIC) | -150.82% | -198.68% | -483.21% | -189.24% | -82.40% |
| Return on Tangible Assets | -149.61% | -193.15% | -588.78% | -112.49% | -109.76% |
| Earnings Yield | -19.50% | -26.34% | -50.06% | -9.24% | -3.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.33 | 51.56 | 45.43 | 47.26 | 29.45 |
| Payables Turnover | 13.46 | 0.42 | 14.40 | 0.14 | 0.36 |
| Inventory Turnover | 275.00 | 3.02 | 0.00 | 0.07 | 0.00 |
| Fixed Asset Turnover | 0.41 | 18.66 | 6.08 | 16.61 | 10.08 |
| Asset Turnover | 0.02 | 1.13 | 1.11 | 0.40 | 0.29 |
| Working Capital Turnover Ratio | 0.07 | -282.71 | 0.60 | 0.51 | 0.61 |
| Cash Conversion Cycle | 249.12 | -731.73 | -17.31 | 2769.22 | -988.64 |
| Days of Sales Outstanding | 274.90 | 7.08 | 8.03 | 7.72 | 12.39 |
| Days of Inventory Outstanding | 1.33 | 120.68 | 0.00 | 5332.43 | 0.00 |
| Days of Payables Outstanding | 27.11 | 859.49 | 25.34 | 2570.93 | 1001.03 |
| Operating Cycle | 276.23 | 127.76 | 8.03 | 5340.15 | 12.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.03 | -0.03 |
| Free Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.03 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -202.88 | -125.86 | -74.59 | -70.19 | -230.12 |
| Capital Expenditure Coverage Ratio | -202.88 | -125.86 | -74.59 | -70.19 | -230.12 |
| Operating Cash Flow Coverage Ratio | -21.10 | -2.64 | -37.46 | -82.24 | -36.53 |
| Operating Cash Flow to Sales Ratio | -61.32 | -0.92 | -3.63 | -2.25 | -2.56 |
| Free Cash Flow Yield | -17.29% | -20.25% | -45.40% | -7.94% | -2.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.14 | -3.80 | -2.00 | -10.82 | -27.56 |
| Price-to-Sales (P/S) Ratio | 356.41 | 4.56 | 8.11 | 28.72 | 99.84 |
| Price-to-Book (P/B) Ratio | 8.36 | 22.03 | 15.80 | 15.14 | 32.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.78 | -4.94 | -2.20 | -12.60 | -38.82 |
| Price-to-Operating Cash Flow Ratio | -5.81 | -4.98 | -2.23 | -12.78 | -38.99 |
| Price-to-Earnings Growth (PEG) Ratio | -0.21 | 0.07 | 0.10 | 1.14 | -1.86 |
| Enterprise Value Multiple | -3.76 | -4.03 | -1.58 | -7.64 | -21.16 |
| Enterprise Value | 27.31M | 14.25M | 13.15M | 84.89M | 234.94M |
| EV to EBITDA | -3.76 | -4.03 | -1.58 | -7.64 | -21.16 |
| EV to Sales | 320.00 | 4.46 | 7.78 | 27.42 | 96.80 |
| EV to Free Cash Flow | -5.19 | -4.84 | -2.11 | -12.03 | -37.64 |
| EV to Operating Cash Flow | -5.22 | -4.88 | -2.14 | -12.20 | -37.80 |
| Tangible Book Value Per Share | 0.01 | -0.00 | 0.00 | 0.02 | 0.03 |
| Shareholders’ Equity Per Share | 0.01 | 0.00 | 0.00 | 0.03 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.00 | 0.20 | 0.00 | 0.27 |
| Revenue Per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Income Per Share | -0.02 | -0.01 | -0.03 | -0.04 | -0.04 |
| Tax Burden | 0.79 | 1.00 | 0.80 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.03 | 1.00 | 0.73 | 0.78 |
| Research & Development to Revenue | 12.19 | 0.43 | 1.39 | 1.18 | 2.13 |
| SG&A to Revenue | 23.69 | 1.60 | 0.84 | 2.37 | 2.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.11 | 0.00 | 0.97 | 1.07 |
| Income Quality | 0.88 | 0.76 | 0.90 | 0.85 | 0.98 |
Currency in AUD